PIK3CA and cancer: This paradoxical observation has also been reported in breast cancer studies of PIK3CA, where some studies found that in early‐stage breast cancer, PIK3CA kinase domain mutations reduced cell chemotaxis, thereby decreasing cancer cell migration and metastasis and improving prognosis.27, 28